• Increased Sexual Desire (Libido): Stimulates the brain’s melanocortin receptors to enhance natural arousal and interest in sexual activity.

• Improved Sexual Satisfaction: Reported improvements in intensity of pleasure, ease of arousal, and ability to orgasm in both men and women.

• Effective for Men & Women: Clinically studied and FDA-approved for Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women; used off-label for men with ED or low libido.

• Fast-Acting Results: Effects typically begin within 30–60 minutes and can last up to 12–24 hours.

Brief Overview

PT-141, also known as Bremelanotide, is a cutting-edge peptide therapy used to enhance sexual desire and performance in both men and women. Unlike other treatments that act on the vascular system (like Viagra or Cialis), PT-141 works directly on the brain’s arousal centers, improving libido and sexual response at the neurological level.

Protocol

Standard Dosing Titration: Dilute one 10mg vial with 2.5mL bacteriostatic water (4mg/mL). Inject 0.08ml (320mcg) Subcutaneously as needed 1-2 hours prior to sexual activity, if well tolerated, increase to 0.13mL (520mcg) per dose, if well tolerated, increase to 0.25mL (1mg) per dose. One 10mg Vial allows for 10-30 doses.

• Duration: as needed prior to sex, max frequency 3x per wk

• Special Instructions: may cause nausea (start at low dose to identify your response)

Pricing

One vial $309 (member $247)

Two Vials $487 (member $387)

Four Vials $787 (member $619)